{"schema_version":"secwatch.filing_event.v1","accession":"0001935979-26-000053","form_type":"8-K","ticker":"BHVN","cik":"0001935979","company_name":"Biohaven Ltd.","filed_at":"2026-07-09T21:11:27+00:00","discovered_at":"2026-07-09T21:12:00.249534+00:00","generated_at":"2026-07-09T21:12:08.250110+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Biohaven CSO Bruce Car retires to part-time Chief Innovation Officer; Pirman promoted to EVP Discovery","bullets":["Bruce Car retires as CSO, becomes part-time Chief Innovation Officer effective July 13, 2026, focusing on external collaborations including Bexorg.","David Pirman promoted to EVP and Head of Discovery, leading internal drug-discovery organization.","Warren Volles, General Counsel and Chief Legal Officer, designated an executive officer.","Dr. Car's salary reduced by 50% to reflect part-time work schedule."],"urls":{"canonical":"https://secwatch.observer/filing/0001935979-26-000053","json":"https://secwatch.observer/filing/0001935979-26-000053.json","markdown":"https://secwatch.observer/filing/0001935979-26-000053.md","text":"https://secwatch.observer/filing/0001935979-26-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1935979/000193597926000053/0001935979-26-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1935979/000193597926000053/bhvn-20260709.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-09T21:12:08.250110+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}